Strategy Inc., led by Michael Saylor, explained how its bitcoin holdings serve as capital while financing and cash reserves generate dollar dividends for investors. The company offers two investment types: common shares (MSTR) for bitcoin exposure and preferred shares (STRC) for steady dollar income with less volatility. STRC pays a 12% annualized dividend twice monthly, with a proposal to switch to daily dividend accruals pending shareholder vote on Oct. 28. Strategy balances raising funds through share issuance and buybacks to maintain dividend payments without selling bitcoin assets, aiming to support income while continuing bitcoin accumulation.
Regarding Strategy Inc.'s bitcoin and dividend strategy, here is Pluang's market snapshot as of Oct 03, 2026 08:02 WIB: Among 50 major cryptocurrencies priced on Pluang, 21 rose and 28 fell today. Notable moves include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, ENJ (Enjin Coin) up 14.39% at Rp612 with 100% sell orders and a typical hold time of 104 days, and BAL (Balancer) up 11.14% at Rp16.297 with a typical hold time of 85 days.
OKB token traded around $120.25 with minimal weekly price change, reflecting a quiet market. The key development is a nearly 10% drop in deposits on X Layer, the Ethereum scaling chain powered by OKB, falling from $186.9 million to $168.3 million sin...
The U.S. Securities and Exchange Commission (SEC) has reportedly approved the first 3x leveraged Bitcoin and Ethereum exchange-traded funds (ETFs) for listing and trading on a U.S. exchange, marking the highest leverage ratio cleared for crypto ETFs ...
Starz Entertainment (STRZ) has achieved over 100% gains year-to-date, supported by improving business fundamentals and attractive valuation. The company recently raised its full-year earnings guidance and committed to deleveraging its balance sheet, ...
Shiba Inu (SHIB) saw a net burn of about 20 billion tokens in the past 24 hours, reflecting modest exchange activity despite a recovering price. The token price has improved since summer lows, currently trading near $0.00000592, and is above a key lo...
Ardent Health's stock is considered undervalued and a 'buy' despite recent declines in profitability. The company’s revenue is growing, with management forecasting $6.4 to $6.7 billion for the year, though EBITDA and cash flow are expected to be lowe...
